ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Pulmonary Disease

Top Pulmonary Disease Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
IMAD FARRUKH MD

Pulmonary Disease

4,344

$828K

259
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 47%

$191
Average prescription price

Avg: $238

CARL HALLENBORG M.D.

Pulmonary Disease

3,613

$581K

242
196 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 47%

$161
Average prescription price

Avg: $238

RUSSELL HIRST M.D.

Pulmonary Disease

3,545

$223K

185
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 47%

$63
Average prescription price

Avg: $238

WILLIAM SADLER M.D.

Pulmonary Disease

3,122

$229K

179
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 47%

$73
Average prescription price

Avg: $238

ANN JEFFERDS MD

Pulmonary Disease

2,572

$144K

223
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 47%

$56
Average prescription price

Avg: $238

CHAKRAVARTHY REDDY MD

Pulmonary Disease

2,543

$142K

82
68 are 65+

23%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 47%

$56
Average prescription price

Avg: $238

JEFFREY KURRUS MD

Pulmonary Disease

2,210

$484K

311
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 47%

$219
Average prescription price

Avg: $238

JAMES PEARL MD

Pulmonary Disease

1,944

$226K

170
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 47%

$116
Average prescription price

Avg: $238

MARK SHOCKEY MD

Pulmonary Disease

1,897

$224K

306
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 47%

$118
Average prescription price

Avg: $238

DOUGLAS ROSS MD

Pulmonary Disease

1,864

$1.45M

190
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 47%

$779
Average prescription price

Avg: $238

TALA'AT AL-SHUQAIRAT MD

Pulmonary Disease

1,858

$312K

318
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 47%

$168
Average prescription price

Avg: $238

WILLIAM WALSH M.D.

Pulmonary Disease

1,849

$90K

98
80 are 65+

37%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 47%

$49
Average prescription price

Avg: $238

BARBARA CAHILL MD

Pulmonary Disease

1,689

$314K

47
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 47%

$186
Average prescription price

Avg: $238

MICHAEL PEARCE MD

Pulmonary Disease

1,386

$522K

162
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 47%

$377
Average prescription price

Avg: $238

MUSTUFA SAIFEE M.D.

Pulmonary Disease

1,376

$764K

292
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 47%

$555
Average prescription price

Avg: $238

BARRY STULTS MD

Pulmonary Disease

1,328

$101K

73
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 47%

$76
Average prescription price

Avg: $238

KURT FRANCIS MD

Pulmonary Disease

1,240

$280K

214
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 47%

$226
Average prescription price

Avg: $238

WILLIAM ALWARD MD

Pulmonary Disease

1,197

$278K

148
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 47%

$233
Average prescription price

Avg: $238

MICHAEL KLINE MD

Pulmonary Disease

1,134

$698K

166
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 47%

$615
Average prescription price

Avg: $238

CARL LAWYER M.D.

Pulmonary Disease

1,089

$190K

178
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 47%

$175
Average prescription price

Avg: $238

SAMER SALEH M.D.

Pulmonary Disease

1,005

$170K

203
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 47%

$169
Average prescription price

Avg: $238

WAYNE SAMUELSON MD

Pulmonary Disease

987

$133K

89
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 47%

$135
Average prescription price

Avg: $238

LYNETTE BROWN M.D., PH.D.

Pulmonary Disease

897

$1.91M

75
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 47%

$2130
Average prescription price

Avg: $238

GREGORY HAMMOND MD

Pulmonary Disease

819

$149K

114
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 47%

$182
Average prescription price

Avg: $238

HOLLY CARVETH MD

Pulmonary Disease

711

$363K

45
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 47%

$511
Average prescription price

Avg: $238

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank